Protocol · Blood Health
Beta-Thalassemia/Hb E Supportive Care Protocol
Vitamin D and Calcium are the core of this stack, with 8 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Beta-Thalassemia/Hb E Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
10 supplements · none graded yet
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file |
|---|---|---|---|---|
| Primary stackThe core of this protocol | ||||
| Vitamin D | Amount listed: 2,000–4,000 IU daily (higher doses if deficient; monitor levels closely) | Bone health critical; thalassemia patients have high osteoporosis risk; deficiency very common | Not graded yet | |
| Calcium | Amount listed: 1,000–1,500 mg daily (from diet + supplements) | Essential for bone health; works with vitamin D; osteoporosis is major complication | Not graded yet | |
| Supporting stackListed as additions to the core | ||||
| Folic Acid | Amount listed: 1–5 mg daily | Increased demand due to accelerated red blood cell production; deficiency can worsen anemia | Not graded yet | |
| Zinc | Amount listed: 15–30 mg daily (monitor levels) | Deficiency common in thalassemia; affects growth, immune function, and wound healing | Not graded yet | |
| Vitamin E | Amount listed: 400–800 IU daily | Antioxidant; protects red blood cells from oxidative damage; may reduce hemolysis | Not graded yet | |
| L-Carnitine | Amount listed: 1–2 g daily | Supports energy metabolism; deficiency may occur with iron chelation therapy | Not graded yet | |
| Vitamin C | Amount listed: 100–250 mg daily (WITH iron chelator only; not during iron overload without chelation) | Enhances iron chelation efficacy; use cautiously with transfusions due to iron concerns | Not graded yet | |
| Magnesium | Amount listed: 300–400 mg daily | Supports bone health; deficiency may occur; important for calcium metabolism | Not graded yet | |
| Vitamin B12 | Amount listed: 500–1,000 mcg daily | Supports red blood cell production; may become depleted with high RBC turnover | Not graded yet | |
| Selenium | Amount listed: 100–200 mcg daily | Antioxidant; supports antioxidant defense against oxidative stress from iron overload | Not graded yet | |
How this protocol works
In plain language
Beta-thalassemia is an inherited blood disorder where the body makes an abnormal form of hemoglobin, leading to anemia and other complications. Hemoglobin E (Hb E) is a variant that when combined with beta-thalassemia creates Hb E/beta-thalassemia, common in Southeast Asia. Severity ranges from mild (thalassemia minor) to severe (thalassemia major requiring regular transfusions).
CRITICAL: Thalassemia requires specialized hematology care. This protocol is SUPPORTIVE ONLY.
PRIMARY MEDICAL MANAGEMENT includes:
- Blood transfusions: Regular transfusions for severe forms to maintain hemoglobin
- Iron chelation: Essential to remove excess iron from transfusions (deferoxamine, deferasirox, deferiprone)
- Splenectomy: In some cases of severe splenic enlargement
- Bone marrow transplant: Potentially curative option for severe disease
- Gene therapy: Emerging treatment
IRON SUPPLEMENTATION IS CONTRAINDICATED in most thalassemia patients due to iron overload from transfusions and enhanced iron absorption.
Vitamin D and Calcium* are critical. Thalassemia patients have very high rates of osteoporosis (up to 50-60%) due to bone marrow expansion, iron overload, and hormonal issues. Bone health support is essential.
Folic Acid* is needed because rapid red blood cell production increases folate demand. Standard recommendation for all hemolytic anemias.
Zinc* deficiency is common and can affect growth, immune function, and wound healing. Monitor levels.
Vitamin E* is an antioxidant that may help protect red blood cells from oxidative damage.
Vitamin C* can enhance iron chelation but should ONLY be used with active chelation therapy, as it increases iron absorption.
Expected timeline: Supplements support long-term health but disease management is lifelong. Regular monitoring of vitamin levels, bone density, and iron status is essential.